The FDA recently revealed a warning letter it sent to Integra LifeSciences‘ (NSDQ:IART) TEI Biosciences over four noted violations it found during an inspection of TEI’s Boston-based facilities. The federal watchdog said that it inspected the company’s facilities where it produces collagen-based medical devices, including its Xenform soft tissue repair matrix, from last October to […]
Integra LifeSciences reveals FDA warning letter over chronic wound treatment
Integra LifeSciences (NSDQ:IART) today revealed its receipt of a warning letter sent by the FDA last week about quality system issues at a Boston-area plant that makes products to treat chronic wounds. Plainsboro, N.J.-based Integra said the FDA inspected the plant last October and November, resulting in a Form 483 covering the problems found there. […]
JenaValve names Kilcoyne as CEO | Personnel Moves – January 15, 2019
JenaValve Technology said today that it named former ReVision Optics prez & CEO John Kilcoyne as its new chief executive officer, effective immediately, replacing Dr. Victoria Carr-Brendell, who has taken up an executive leadership position with Sonova Holding AG (SIX:SOON). Prior to his time at ReVision Optics, Kilcoyne served as prez & CEO at Micrus Endovascular where he […]
Boston Scientific shares tick up after Q4 prelims meet estimates | Wall Street Beat
Shares in Boston Scientific (NYSE:BSX) rose slightly this morning after the company reported preliminary results for the fourth quarter and full year of 2018 that were in-line with estimates on Wall Street. The Marlborough, Mass.-based company said it expects to report $2.56 billion in sales for the fourth quarter and $9.82 billion for the full year. […]
Google taps ex-Geisinger CEO Feinberg to lead consolidated Google Health biz | Personnel Moves – November 14, 2018
Google (NSDQ:GOOG) has picked up former Geisinger Health CEO David Feinberg to lead its fragmented health divisions under the Google Health moniker, according to a recent CNBC report. The tech giant had been searching for a head for several months, with artificial intelligence head Jeff Dean heavily involved in the process, according to the report. Other […]
Integra LifeSciences dives on Q3 sales miss, lowered outlook
Integra LifeSciences (NSDQ:IART) shares took a dive today after the medical device company missed expectations for its third-quarter sales and lowered its top-line outlook for the rest of the year. Plainsboro, N.J.-based Integra posted profits of $13.3 million, or 15¢ per share, on sales of $365.9 million for the three months ended Sept. 30, amounting […]
Motus GI taps Moran as CEO | Personnel Moves – September 25, 2018
Motus GI said today that it named Timothy Moran as its new chief executive officer, effective October 1, replacing former CEO Mark Pomeranz who will assume the role of president and COO. Moran has previously served ConvaTec‘s (LON:CTEC) Americas president and helped lead the company through its initial public offering in 2016. Prior to ConvaTec, Moran spent […]
The 10 most innovative medical devices of 2018
The nominees for the best medical technology of 2018 were recently announced for the 12th Annual Prix Galien USA Awards. The host of the awards, The Galien Foundation, awards the Prix Galien Award annually to examples of outstanding biomedical and technology product achievements that are designed to improve human condition. Before the candidates can qualify […]
Integra LifeSciences down on Q2 sales miss
Shares in Integra LifeSciences (NSDQ:IART) fell today after the medical device maker missed sales expectations on Wall Street with its second quarter results. The Plainsboro, N.J.-based company posted profits of $11.4 million, or 14¢ per share, on sales of $366.2 million for the three months ended June 30, for bottom-line growth of 5% while sales grew […]
Integra LifeSciences closes $350m offering
Integra LifeSciences (NSDQ:IART) said yesterday it closed a $350 million offering of common stock, which included a fully exercised underwriter’s option. In the recently closed offering, the Plainsboro, N.J.-based company floated approximately 5.3 million shares of common stock at $58.50 per share. The offering included a 30-day underwriter’s option to purchase an additional 787,500 shares of common […]
Integra LifeSciences prices $307m offering, extends BofA loan
Integra LifeSciences (NSDQ:IART) this week priced a public offering worth up to $307 million and announced it amended an existing credit facility with a bank group led by Bank of America. In its upcoming offering, the Plainsboro, N.J.-based company said it plans to float approximately 5.3 million shares of common stock at $58.50 per share. The offering […]
- 1
- 2
- 3
- …
- 8
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube